Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
The 65th Annual Scientific Meeting of the British Society for Haematology (BSH 2025) is the UK’s largest haematology conference, bringing together professionals, researchers, and industry leaders to share knowledge, innovations, and best practices in the field.
Why attend BSH in 2025?
Gain insights from renowned speakers covering key haematology topics.
Explore cutting-edge developments in haematology, including parallel sessions, abstract presentations, and industry educational sessions.
Connect with peers, researchers, and leading organisations to build valuable professional relationships.
Attend focused sessions on haematology essentials, lymphoma, transplant medicine, myeloid malignancies, AI in haematology, and more.
Event highlights
Plasma cell dyscrasias – Latest advancements in multiple myeloma, amyloidosis, and related conditions.
Transplant medicine – Updates on stem cell transplantation and evolving treatment protocols.
Myeloid & acute leukaemias – Exploring potential overlaps and emerging therapies relevant to plasma cell disorders.
Industry educational sessions – Insights into novel drug developments and clinical trials in myeloma.
Whether you are a clinician, researcher, or student, BSH 2025 offers an exceptional opportunity to expand your knowledge and engage with the haematology community.
–
